Is it reasonable to request a third Cardioversion

A third cardioversion can work, but the chance of staying in sinus rhythm for a year is roughly 50% or less, depending on your heart's condition.

The evidence shows that electrical cardioversion initially restores sinus rhythm in 70–90% of patients [3], but atrial fibrillation returns within a year in 60–75% of them, often within the first month [3]. The key question is whether a third attempt is worth it. The answer depends on what is driving the recurrence.

Several studies identify strong predictors of failure. A larger left atrium is a major one: each 5 mm increase in left atrial diameter roughly triples the odds of cardioversion failure [1]. Older age, longer duration of atrial fibrillation, and the presence of heart failure also reduce success [2]. On the other hand, if the arrhythmia is atrial flutter rather than fibrillation, success is more likely [2]. Pretreatment with amiodarone can salvage some cases: in patients who had already failed a prior cardioversion, amiodarone loading followed by repeat shock restored sinus rhythm in 65% of patients, with 52% still in sinus rhythm at one year [5].

The evidence does not directly compare a third cardioversion to alternatives like catheter ablation or rate control. But ablation has been shown to keep more patients free of atrial fibrillation than antiarrhythmic drugs alone (66% vs 16% at 9 months in one trial) [4], and it may be a better long-term option for patients with structural heart disease or large atria. Rate control is another reasonable path that avoids repeated shocks.

A third cardioversion is reasonable if your left atrium is not severely enlarged, the arrhythmia is recent-onset or atrial flutter, and you are willing to accept a roughly 50% chance of staying in sinus rhythm for a year. Pretreatment with amiodarone or another antiarrhythmic drug can improve those odds. But if your left atrium is large or you have already failed two attempts, the likelihood of lasting benefit is low, and catheter ablation or rate control should be discussed.

My call: a third cardioversion can be reasonable in selected patients with favorable predictors, but the evidence does not support it as a default for everyone. Confidence: moderate – the studies are indirect and do not specifically study third attempts.